Literature DB >> 35093974

Uterine Leiomyosarcoma Associated With Leiomyoma With Bizarre Nuclei: Histology and Genomic Analysis of 2 Cases.

Jean V Fischer1, Melissa Mejia-Bautista, Brian Vadasz, Ping Yin, Serdar Bulun, Edward J Tanner, Xinyan Lu, Jian-Jun Wei.   

Abstract

Leiomyoma with bizarre nuclei (LM-BN) is a rare variant of leiomyoma with overall benign clinical course. It has histologic features showing focal or diffuse nuclear atypia surrounded by usual type leiomyoma. Uterine leiomyosarcomas (LMS) are a group of rare and aggressive malignancies with limited treatment options available. The potential association between LM-BN with LMS is largely unknown. In this study, we report 2 cases of uterine smooth muscle tumor with typical histologic and molecular evidence of LM-BN, which are associated with its progression to the malignant counterpart of LMS. We summarize the detailed histologic, morphologic, and genomic characteristics of these 2 sets of cases. Our findings suggest that LMS progressing from preexisting LM-BN can be one of the tumor pathogenesis pathways in uterine leiomyomas.
Copyright ©2022International Society of Gynecological Pathologists.

Entities:  

Year:  2022        PMID: 35093974      PMCID: PMC9339039          DOI: 10.1097/PGP.0000000000000837

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   3.326


  32 in total

1.  Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways.

Authors:  Tine Cuppens; Matthieu Moisse; Jeroen Depreeuw; Daniela Annibali; Eva Colas; Antonio Gil-Moreno; Jutta Huvila; Olli Carpén; Michal Zikán; Xavier Matias-Guiu; Philippe Moerman; Sabrina Croce; Diether Lambrechts; Frédéric Amant
Journal:  Int J Cancer       Date:  2017-11-07       Impact factor: 7.396

2.  Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases.

Authors:  S W Bell; R L Kempson; M R Hendrickson
Journal:  Am J Surg Pathol       Date:  1994-06       Impact factor: 6.394

3.  MED12 exon 2 mutations in histopathological uterine leiomyoma variants.

Authors:  Netta Mäkinen; Pia Vahteristo; Kati Kämpjärvi; Johanna Arola; Ralf Bützow; Lauri A Aaltonen
Journal:  Eur J Hum Genet       Date:  2013-02-27       Impact factor: 4.246

4.  Molecular and immunohistochemical evidence for the origin of uterine leiomyosarcomas from associated leiomyoma and symplastic leiomyoma-like areas.

Authors:  Khush R Mittal; Fan Chen; Jian J Wei; Kiran Rijhvani; Rohini Kurvathi; Deanna Streck; James Dermody; Gokce A Toruner
Journal:  Mod Pathol       Date:  2009-07-24       Impact factor: 7.842

5.  Differential diagnosis of smooth muscle tumors utilizing p53, pTEN and Ki-67 expression with estrogen and progesterone receptors.

Authors:  Hüsnü Gökaslan; Levent Türkeri; Zehra Neşe Kavak; Funda Eren; Alper Sişmanoğlu; Sennur Ilvan; Fatih Durmuşoğlu
Journal:  Gynecol Obstet Invest       Date:  2004-09-20       Impact factor: 2.031

6.  Atypical leiomyomas of the uterus: a clinicopathologic study of 51 cases.

Authors:  Amy Ly; Anne M Mills; Jesse K McKenney; Bonnie L Balzer; Richard L Kempson; Michael R Hendrickson; Teri A Longacre
Journal:  Am J Surg Pathol       Date:  2013-05       Impact factor: 6.394

7.  Genomic signatures predict poor outcome in undifferentiated pleomorphic sarcomas and leiomyosarcomas.

Authors:  Sara Martoreli Silveira; Rolando Andre Rios Villacis; Fabio Albuquerque Marchi; Mateus de Camargo Barros Filho; Sandra Aparecida Drigo; Cristovam Scapulatempo Neto; Ademar Lopes; Isabela Werneck da Cunha; Silvia Regina Rogatto
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

8.  Integrative genomic and transcriptomic analysis of leiomyosarcoma.

Authors:  Priya Chudasama; Sadaf S Mughal; Mathijs A Sanders; Daniel Hübschmann; Inn Chung; Katharina I Deeg; Siao-Han Wong; Sophie Rabe; Mario Hlevnjak; Marc Zapatka; Aurélie Ernst; Kortine Kleinheinz; Matthias Schlesner; Lina Sieverling; Barbara Klink; Evelin Schröck; Remco M Hoogenboezem; Bernd Kasper; Christoph E Heilig; Gerlinde Egerer; Stephan Wolf; Christof von Kalle; Roland Eils; Albrecht Stenzinger; Wilko Weichert; Hanno Glimm; Stefan Gröschel; Hans-Georg Kopp; Georg Omlor; Burkhard Lehner; Sebastian Bauer; Simon Schimmack; Alexis Ulrich; Gunhild Mechtersheimer; Karsten Rippe; Benedikt Brors; Barbara Hutter; Marcus Renner; Peter Hohenberger; Claudia Scholl; Stefan Fröhling
Journal:  Nat Commun       Date:  2018-01-10       Impact factor: 14.919

9.  Integrated histologic and molecular analysis of uterine leiomyosarcoma and 2 benign variants with nuclear atypia.

Authors:  Tingting Gao; Brian S Finkelman; Yanli Ban; Yinuo Li; Ping Yin; Serdar E Bulun; Xinyan Lu; Chunfang Ha; Jian-Jun Wei
Journal:  Cancer Sci       Date:  2021-03-22       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.